UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition Xylocain-2-Gel-SE-AJ-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-100001718-00004114, http://ema.europa.eu/fhir/eurdId
/10933
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Gel
indication:
Ytanestesi av uretra vid kateterisering, sondering samt andra endouretrala ingrepp. Ytanestesi vid ano-, rekto- och sigmoidoskopi samt vid rektal palpation. Smärtsamma cystiter. Xylocain gel är avsett för vuxna och barn i alla åldrar.
legalStatusOfSupply: Medicinal product subject to medical prescription
classification: lidocaine
name
productName: Xylocain 2% Gel
part
part: Xylocain
type: Invented Name Part
part
part: 2%
type: Strength part
part
part: Gel
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish